Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron M Gusdon

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Neurocritical Care|February 15, 2024
Assessing Acute Brain Injury after Rapid Reduction of PaCO<sub>2</sub> using Plasma Biomarkers in Patients Undergoing ECMOSung-Min Cho, Aaron M Gusdon
Antioxidants & Redox Signaling|December 4, 2010
To eat or not to eat: neuronal metabolism, mitophagy, and Parkinson's diseaseAaron M Gusdon, Charleen T Chu
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|January 30, 2019
Clinical and EEG Characteristics of Ifosfamide-Related EncephalopathyAaron M Gusdon, Rachna Malani, Xi Chen
Current Opinion in Lipidology|April 15, 2016
Effects of melatonin on cardiovascular diseases: progress in the past yearHang Sun, Aaron M Gusdon, Shen Qu
Journal of Thrombosis and Thrombolysis|January 24, 2023
Correction to: Timing of anticoagulation for venous thromboembolism after recent traumatic and vascular brain injurySophie Samuel, Carlton Menchaca, Aaron M Gusdon
Annals of Translational Medicine|February 12, 2019
Weight or metabolism: which deserve more attention in obesity?Bing Zhu, Aaron M Gusdon, Shen Qu
Journal of Thrombosis and Thrombolysis|December 8, 2022
Timing of anticoagulation for venous thromboembolism after recent traumatic and vascular brain InjurySophie Samuel, Carlton Menchaca, Aaron M Gusdon
World Journal of Gastroenterology|December 24, 2013
Cross-talk between the thyroid and liver: a new target for nonalcoholic fatty liver disease treatmentYue-Ye Huang, Aaron M Gusdon, Shen Qu
Oxidative Medicine and Cellular Longevity|November 6, 2014
Nonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspectiveAaron M Gusdon, Ke-Xiu Song, Shen Qu
Lipids in Health and Disease|November 12, 2013
Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategiesYue Ye Huang, Aaron M Gusdon, Shen Qu
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Neurocritical Care|February 15, 2024
Assessing Acute Brain Injury after Rapid Reduction of PaCO<sub>2</sub> using Plasma Biomarkers in Patients Undergoing ECMOSung-Min Cho, Aaron M Gusdon
Antioxidants & Redox Signaling|December 4, 2010
To eat or not to eat: neuronal metabolism, mitophagy, and Parkinson's diseaseAaron M Gusdon, Charleen T Chu
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|January 30, 2019
Clinical and EEG Characteristics of Ifosfamide-Related EncephalopathyAaron M Gusdon, Rachna Malani, Xi Chen
Current Opinion in Lipidology|April 15, 2016
Effects of melatonin on cardiovascular diseases: progress in the past yearHang Sun, Aaron M Gusdon, Shen Qu
Journal of Thrombosis and Thrombolysis|January 24, 2023
Correction to: Timing of anticoagulation for venous thromboembolism after recent traumatic and vascular brain injurySophie Samuel, Carlton Menchaca, Aaron M Gusdon
Annals of Translational Medicine|February 12, 2019
Weight or metabolism: which deserve more attention in obesity?Bing Zhu, Aaron M Gusdon, Shen Qu
Journal of Thrombosis and Thrombolysis|December 8, 2022
Timing of anticoagulation for venous thromboembolism after recent traumatic and vascular brain InjurySophie Samuel, Carlton Menchaca, Aaron M Gusdon
World Journal of Gastroenterology|December 24, 2013
Cross-talk between the thyroid and liver: a new target for nonalcoholic fatty liver disease treatmentYue-Ye Huang, Aaron M Gusdon, Shen Qu
Oxidative Medicine and Cellular Longevity|November 6, 2014
Nonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspectiveAaron M Gusdon, Ke-Xiu Song, Shen Qu
Lipids in Health and Disease|November 12, 2013
Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategiesYue Ye Huang, Aaron M Gusdon, Shen Qu
Pageof 9